We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0RK9 market cap is 5.1B. The company's latest EPS is SEK -1.1221 and P/E is -20.50.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 4.36M | 5.52M | 13.33M | 36.03M | 61.9M |
| Operating Income | -213.17M | -144.04M | -141.36M | -192.3M | -248.98M |
| Net Income | -210.11M | -143.3M | -141.74M | -193.4M | -248.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 311.13M | 151.94M | 333.2M | 169.58M | 118.45M |
| Total Liabilities | 52.63M | 36.69M | 50.93M | 80.53M | 106.6M |
| Total Equity | 258.5M | 115.24M | 282.27M | 89.05M | 11.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -178.96M | -141.35M | -127.03M | -172.61M | -189.29M |
| Investing | 17.82M | 156.89M | -45k | -440k | -2.46M |
| Financing | -6.3M | -6.15M | 301.8M | -7.83M | 161.56M |
| Market Cap | 5.1B |
| Price to Earnings Ratio | -20.50 |
| Price to Sales Ratio | 82.32 |
| Price to Cash Ratio | 77.05 |
| Price to Book Ratio | 429.8 |
| Dividend Yield | - |
| Shares Outstanding | 221.54M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 23.00 |
| 52 Week Low | 23.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Alligator Bioscience Ab |
| Address |
medicon village lund 223 81 |
| Website | https://www.alligatorbioscience.se |
| Industry | noncomml resh organizations (8733) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
